Abakan, Inc. ABKI Company Overview  Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Abakan, Inc. ABKI Company Overview 

Stock Message Board http://investorshangout.com/search?q=ABKI&...mp;yt1=Go!

Abakan, Inc. ABKI Current Price and Quotes
Last Price 2.05
Previous Close 2.05 Open 2.05
Daily Range 2.05 - 1.98 52wk Range 3.50 - 1.60
Volume 14,478 Dividend N/A
Average Vol (3m) 15,829 Yield N/A
Abakan, Inc. ABKI
Company Information

2665 S. Bayshore Drive
Suite 450
Miami, FL 33133

Website: http://www.abakaninc.com
Phone: 786-206-5368

Abakan, Inc. ABKI
Abakan, Inc. ABKI
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report May 31, 2013 10-K
CIK 0001400000
Fiscal Year End 5/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 3470 - Coating, Engraving & Allied Services
Incorporated In: NV, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Robert Miller CEO
David Charbonneau CFO, Principal Acct. Officer
Company Directors

James S.B. Chew
Theodore Sarniak, III
Robert Miller
Company Notes

Formerly=Waste to Energy Group, Inc. until 12-2009
Formerly=Your Digital Memories, Inc. until 9-2008
Service Providers

Auditor/Accountant
Skoda, Minotti & Co., Certified Public Accountants
6685 Beta Drive
Mayfield Village, OH, 44143
United States

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Abakan, Inc. ABKI
ABKI Security Details

Share Structure

Market Value1 $124,571,376 a/o Sep 30, 2013
Shares Outstanding 60,766,525 a/o Apr 16, 2012
Float Not Available
Authorized Shares Not Available
Par Value  0.0001
Shareholders

Shareholders of Record 464 a/o Sep 13, 2012
Security Notes

Capital Change=shs increased by 25 for 1 split. Payable upon surrender.. Pay date=09/04/2008.
Short Selling Data

Short Interest 23,100 (-6.98%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Island Stock Transfer

Abakan, Inc. ABKI Recent News

Sept 16, 2013 Abakan's Subsidiary, MesoCoat, Signs Exclusive Sales Agreement with Metallurgic Solutions, S.A. de CV for Mexico and Central America
Sept 12, 2013 OTC Signal Daily Stock Watch - Abakan Inc. (OTCBB: ABKI)
Aug 22, 2013 MesoCoat Inc. Ranked #15 Fastest-Growing Manufacturing Company in the Annual Inc. 500|5000 list of Fastest-Growing Companies in the U.S.
Aug 19, 2013 OTC Daily Alert Stock Watch - Abakan (OTCQB: ABKI)
Aug 13, 2013 New high-tech company launched in Euclid
Aug 6, 2013 Abakan Announces Incorporation of MesoCoat Coating Services Inc. to Accelerate Entry in the High Value Coating Services Market
Jul 23, 2013 Abakan Launches Terves Inc. to Commercialize Proprietary Reactive Materials Technology Designed to Improve the Safety and Efficiency of Oil and Gas Well Isolation, Perforation, and Completion


Abakan, Inc. ABKI Financials
Period Ending May 31, 2013 May 31, 2012 May 31, 2011 May 31, 2010
Total Revenue 1,847 2,939 - -
Cost of Revenue 739 1,049 - -
Gross Profit 1,108 1,890 - -
Operating Expenses

Research and Development 1,347 737 - -
Sales, General and Admin. 6,144 4,373 2,674 1,396
Non-Recurring Items - - - -
Other 417 303 6 10
Operating Income (6,800) (3,523) (2,680) (1,405)
Income From Continuing Operations

Add'l Income/Expense Items (215) 2,251 198 1
Earnings Before Interest and Tax (7,276) (328) (2,761) (1,596)
Interest Expense 1,061 750 424 11
Earnings Before Tax (8,337) (1,077) (3,185) (1,607)
Income Tax - - - -
Minority Interest (1,114) 42 - -
Equity Earnings Unconsolidated Subsidiary (261) 944 (278) (192)
Net Income Cont. Operations (7,484) (175) (3,463) (1,798)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (7,223) (1,119) (3,185) (1,607)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (7,223) (1,119) (3,185) (1,607)

ABKI Abakan, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=ABKI&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/ABKI/quote
Stock Chart http://www.otcmarkets.com/stock/ABKI/chart
Company Info http://www.otcmarkets.com/stock/ABKI/company-info
Recent News http://www.otcmarkets.com/stock/ABKI/news
Financials http://www.otcmarkets.com/stock/ABKI/financials
Filings and Disclosure http://www.otcmarkets.com/stock/ABKI/filings
Short Sales http://www.otcmarkets.com/stock/ABKI/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/ABKI/insider-transactions
Research Reports http://www.otcmarkets.com/stock/ABKI/research
Summary http://finance.yahoo.com/q?s=ABKI
Historical Prices http://finance.yahoo.com/q/hp?s=ABKI+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=ABKI
Basic Chart http://finance.yahoo.com/q/bc?s=ABKI+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=ABKI+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=ABKI+Headlines
Press Releases http://finance.yahoo.com/q/p?s=ABKI+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=ABKI+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=ABKI+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=ABKI+Industry
Major Holders http://finance.yahoo.com/q/mh?s=ABKI+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=ABKI+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=ABKI+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=ABKI
Balance Sheet http://finance.yahoo.com/q/bs?s=ABKI
Cash Flow http://finance.yahoo.com/q/cf?s=ABKI+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/ABKI
Market Watch http://www.marketwatch.com/investing/stock/ABKI
Bloomberg http://www.bloomberg.com/quote/ABKI:US
Morningstar http://quotes.morningstar.com/stock/s?t=ABKI
Bussinessweek http://investing.businessweek.com/research/st...icker=ABKI
Barchart http://www.barchart.com/quotes/stocks/ABKI
OTC Short Report http://otcshortreport.com/index.php?index=ABKI
Investopedia http://www.investopedia.com/markets/stocks/ABKI/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Therapeutics Gains Confidence with Strategic Developments

Updated Category News Views 60

Piper Sandler's Renewed Confidence in Context Therapeutics Piper Sandler has reiterated an Overweight rating for Context Therapeutics (NASDAQ: CNTX), maintaining a price target of $4.50 for the stock. This endorsement underscores their belief in the company’s potential within the biopharmaceutical sector. Positive Data from Competitors Enhances Expectations This renewed...

Continue Reading
Actinium's ATNM-400: A Promising Frontier in Prostate Cancer Therapy

Updated Category News Views 167

Introduction to ATNM-400's Innovative Approach Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) has announced compelling preclinical data showcasing its innovative treatment, ATNM-400. This first-in-class antibody radioconjugate targets a unique, non-PSMA antigen, revolutionizing prostate cancer therapy. ATNM-400 offers noteworthy therapeutic activity independent of...

Continue Reading
Opportunity Knocks: Ligon's Major Auction Up for Bids

Updated Category News Views 17

Equipment Auction Offers Unique Buying Opportunity Catch this: Ligon Co.'s auction is like finding a needle in a haystack in a world of overpriced equipment. We're talking about a smorgasbord of heavy machinery up for online grabs, and it’s happening until June 17. Auction Highlights: Your Next Business Asset? From telehandlers to trailers, this ain't your everyday yard...

Continue Reading
Selector Enhances Service Delivery with AWS Marketplace Launch

Updated Category News Views 147

Selector Launches on AWS Marketplace for Better Accessibility Selector, a pioneer in AI-driven observability and network intelligence, is transforming how organizations manage their network operations. The company has launched its flagship platform on the Amazon Web Services (AWS) Marketplace, which makes it easier for customers to procure and deploy its powerful AI tools...

Continue Reading
Exploring the Surge in Decentralized Energy Storage Growth

Updated Category News Views 229

Decentralized Energy Storage Market Overview The Decentralized Energy Storage market is gaining remarkable traction, with significant insights indicating a shift towards sustainable energy solutions. Valued at approximately USD 10.88 billion, the market is anticipated to expand to a staggering USD 35.62 billion, exhibiting a compound annual growth rate (CAGR) of 15.98%...

Continue Reading